UB Paderborn / Katalog / Suche / in CDI

1 – 25 von 138

Sortiert nach

Age, JAK2(V617F) and SF3B1 mutations are the main predicting factors for survival in refractory anaemia with ring sideroblasts and marked thrombocytosis

Leukemia, 2013-09, Vol.27 (9), p.1826-1831

2013

Volltextzugriff (PDF)

Differential association of calreticulin type 1 and type 2 mutations with myelofibrosis and essential thrombocytemia: relevance for disease evolution

Leukemia, 2015-01, Vol.29 (1), p.249-252

2015

Volltextzugriff (PDF)

Low rate of calreticulin mutations in refractory anaemia with ring sideroblasts and marked thrombocytosis

Leukemia, 2014-06, Vol.28 (6), p.1374-1376

2014

Volltextzugriff (PDF)

Dual regulation of SPI1/PU.1 transcription factor by heat shock factor 1 (HSF1) during macrophage differentiation of monocytes

Leukemia, 2014-08, Vol.28 (8), p.1676-1686

2014

Volltextzugriff (PDF)

Paroxysmal nocturnal hemoglobinuria and pregnancy before the eculizumab era: the French experience

Haematologica (Roma), 2011-09, Vol.96 (9), p.1276-1283

2011

Volltextzugriff (PDF)

A new case of rare erythrocytosis due to EGLN1 mutation with review of the literature

La revue de medecine interne, 2020-03, Vol.41 (3), p.196-199

2020

Volltextzugriff (PDF)

Endogenous megakaryocytic colonies underline association between megakaryocytes and calreticulin mutations in essential thrombocythemia

Haematologica (Roma), 2015-05, Vol.100 (5), p.e176

2015

Volltextzugriff (PDF)

Concordance of assays designed for the quantification of JAK2V617F: a multicenter study

Haematologica (Roma), 2009-01, Vol.94 (1), p.38-45

2009

Volltextzugriff (PDF)

Frequent reduction or absence of detection of the JAK2-mutated clone in JAK2V617F-positive patients within the first years of hydroxyurea therapy

Haematologica (Roma), 2008-11, Vol.93 (11), p.1723-1727

2008

Volltextzugriff (PDF)

Significant increase in the apparent incidence of essential thrombocythemia related to new WHO diagnostic criteria: a population-based study

Haematologica (Roma), 2009-06, Vol.94 (6), p.865-869

2009

Volltextzugriff (PDF)

The 'GGCC' haplotype of JAK2 confers susceptibility to JAK2 exon 12 mutation-positive polycythemia vera

Leukemia, 2009-10, Vol.23 (10), p.1924-1926

2009

Volltextzugriff (PDF)

Leukocytosis is associated with poor survival but not with increased risk of thrombosis in essential thrombocythemia: a population-based study of 311 patients

Leukemia, 2010-04, Vol.24 (4), p.900-903

2010

Volltextzugriff (PDF)

P1065: CONGENITAL ERYTHROCYTOSIS DUE TO HETEROZYGOUS VARIANTS IN THE BISPHOSPHOGLYCERATE MUTASE GENE

HemaSphere, 2022-06, Vol.6 (Suppl), p.955-956

2022

Volltextzugriff (PDF)

GSI-I (Z-LLNle-CHO) inhibits γ-secretase and the proteosome to trigger cell death in precursor-B acute lymphoblastic leukemia

Leukemia, 2011-07, Vol.25 (7), p.1135-1146

2011

Volltextzugriff (PDF)

Evaluation of mean sphered corpuscular volume for predicting hereditary spherocytosis

International journal of laboratory hematology, 2010-10, Vol.32 (5), p.519-523

2010

Volltextzugriff (PDF)

Calreticulin mutations, a new diagnostic tool for the myeloproliferative disorders

La revue de medecine interne, 2015-12, Vol.36 (12), p.791-793

2015

Volltextzugriff (PDF)

Identification of a new VHL exon and complex splicing alterations in familial erythrocytosis or von Hippel-Lindau disease

Blood, 2018-08, Vol.132 (5), p.469-483

2018

Volltextzugriff (PDF)

Hypereosinophilia as a presenting feature of anaplastic large cell lymphoma

British journal of haematology, 2008-02, Vol.140 (4), p.363-363

2008

Volltextzugriff (PDF)

Twenty-five years of epidemiological recording on myeloid malignancies: data from the specialized registry of hematologic malignancies of Côte d’Or (Burgundy, France)

Haematologica (Roma), 2011-01, Vol.96 (1), p.55-61

2011

Volltextzugriff (PDF)

Mutations with epigenetic effects in myeloproliferative neoplasms and recent progress in treatment: Proceedings from the 5th International Post-ASH Symposium

Blood cancer journal (New York), 2011-03, Vol.1 (3), p.e7-e7

2011

Volltextzugriff (PDF)

Increase therapy-related leukemia secondary to breast cancer

Leukemia, 2000-06, Vol.14 (6), p.1014-1017

2000

Volltextzugriff (PDF)

Incidence of chronic Philadelphia chromosome negative (Ph−) myeloproliferative disorders in the Côte d'Or area, France, during 1980–99

Journal of internal medicine, 2005-07, Vol.258 (1), p.90-91

2005

Volltextzugriff (PDF)

Polyglobulie rare par mutation du gène EGLN1 : à propos d’un cas et revue de la littérature

La revue de medecine interne, 2020-03, Vol.41 (3), p.196-199

2020

Volltextzugriff (PDF)

1 – 25 von 138

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(122)
Mit Volltextzugriff
(121)

Publikationsform

Sprache

Erscheinungsjahr

n.n

Thema

Humans
(78)
Science & Technology
(74)
Life Sciences & Biomedicine
(72)
Female
(40)
Male
(39)
Biological And Medical Sciences
(33)
Hematology
(33)
Medical Sciences
(31)
Mutation
(30)
Adult
(23)
Aged
(23)
Cystic Fibrosis Transmembrane Conductance Regulator - Genetics
(21)
Life Sciences
(20)
Middle Aged
(18)
Cystic Fibrosis - Genetics
(16)
Hematologic And Hematopoietic Diseases
(16)
Genetics & Heredity
(15)
Aged, 80 And Over
(13)
Leukemias. Malignant Lymphomas. Malignant Reticulosis. Myelofibrosis
(12)
Oncology
(12)

15 weitere anzeigen...

Weniger anzeigen...

Zeitschrift / Serie

5 weitere anzeigen...

Weniger anzeigen...

Menü

Weitere Dienste

Einstellungen

Age, JAK2(V617F) and SF3B1 mutations are the main predicting factors for survival in refractory anaemia with ring sideroblasts and marked thrombocytosis

Differential association of calreticulin type 1 and type 2 mutations with myelofibrosis and essential thrombocytemia: relevance for disease evolution

Low rate of calreticulin mutations in refractory anaemia with ring sideroblasts and marked thrombocytosis

Dual regulation of SPI1/PU.1 transcription factor by heat shock factor 1 (HSF1) during macrophage differentiation of monocytes

Paroxysmal nocturnal hemoglobinuria and pregnancy before the eculizumab era: the French experience

A new case of rare erythrocytosis due to EGLN1 mutation with review of the literature

Endogenous megakaryocytic colonies underline association between megakaryocytes and calreticulin mutations in essential thrombocythemia

Concordance of assays designed for the quantification of JAK2V617F: a multicenter study

Frequent reduction or absence of detection of the JAK2-mutated clone in JAK2V617F-positive patients within the first years of hydroxyurea therapy

Significant increase in the apparent incidence of essential thrombocythemia related to new WHO diagnostic criteria: a population-based study

The 'GGCC' haplotype of JAK2 confers susceptibility to JAK2 exon 12 mutation-positive polycythemia vera

Leukocytosis is associated with poor survival but not with increased risk of thrombosis in essential thrombocythemia: a population-based study of 311 patients

P1065: CONGENITAL ERYTHROCYTOSIS DUE TO HETEROZYGOUS VARIANTS IN THE BISPHOSPHOGLYCERATE MUTASE GENE

GSI-I (Z-LLNle-CHO) inhibits γ-secretase and the proteosome to trigger cell death in precursor-B acute lymphoblastic leukemia

Evaluation of mean sphered corpuscular volume for predicting hereditary spherocytosis

Calreticulin mutations, a new diagnostic tool for the myeloproliferative disorders

Single-cell multi-omics identifies chronic inflammation as a driver of TP53-mutant leukemic evolution

Identification of a new VHL exon and complex splicing alterations in familial erythrocytosis or von Hippel-Lindau disease

Hypereosinophilia as a presenting feature of anaplastic large cell lymphoma

Twenty-five years of epidemiological recording on myeloid malignancies: data from the specialized registry of hematologic malignancies of Côte d’Or (Burgundy, France)

Clinical features and course of refractory anemia with ring sideroblasts associated with marked thrombocytosis

Mutations with epigenetic effects in myeloproliferative neoplasms and recent progress in treatment: Proceedings from the 5th International Post-ASH Symposium

Increase therapy-related leukemia secondary to breast cancer

Incidence of chronic Philadelphia chromosome negative (Ph−) myeloproliferative disorders in the Côte d'Or area, France, during 1980–99

Polyglobulie rare par mutation du gène EGLN1 : à propos d’un cas et revue de la littérature

Suchergebnisse filtern